Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -97.06%40.91K | -58.95%458.31K | -93.74%103.88K | -53.69%5.29M | -49.77%1.13M | -29.74%1.39M | -71.17%1.12M | -50.25%1.66M | 41.55%11.43M | -46.54%2.24M |
| Selling and administrative expenses | -97.11%39.72K | -59.51%447.78K | -94.32%93.16K | -53.10%5.24M | -49.77%1.12M | -30.08%1.37M | -70.03%1.11M | -50.12%1.64M | 40.47%11.17M | -46.49%2.23M |
| -Selling and marketing expense | --0 | --0 | -84.04%4.03K | -82.70%158.27K | -95.96%23.68K | -15.47%72.47K | -59.88%36.85K | -83.25%25.26K | -3.24%914.65K | 132.86%586.26K |
| -General and administrative expense | -96.95%39.72K | -58.11%447.78K | -94.48%89.13K | -50.46%5.08M | -33.31%1.1M | -30.75%1.3M | -70.29%1.07M | -48.53%1.61M | 46.37%10.26M | -58.01%1.65M |
| Other operating expenses | -93.05%1.19K | -0.91%10.53K | -44.30%10.72K | -79.40%52.76K | -50.02%5.81K | 14.69%17.09K | -94.17%10.63K | -59.40%19.24K | 113.16%256.13K | -54.11%11.62K |
| Operating profit | 97.06%-40.91K | 58.95%-458.31K | 93.74%-103.88K | 53.69%-5.29M | 49.77%-1.13M | 29.74%-1.39M | 71.17%-1.12M | 50.25%-1.66M | -41.55%-11.43M | 46.54%-2.24M |
| Net non-operating interest income (expenses) | 8.38%-353.88K | 15.57%-380.64K | 19.51%-369.95K | 28.60%-1.68M | 24.70%-383.57K | 27.28%-386.23K | 28.22%-450.82K | 32.86%-459.63K | 35.05%-2.35M | 42.54%-509.38K |
| Non-operating interest income | -3.34%88.99K | -23.19%88.57K | -6.15%93.3K | 33.54%407.57K | -9.64%100.79K | 12.19%92.06K | 30.24%115.31K | 331.18%99.41K | 244.67%305.19K | 189.85%111.54K |
| Non-operating interest expense | -7.41%442.87K | -17.12%469.21K | -17.13%463.26K | -21.46%2.09M | -21.99%484.36K | -21.99%478.29K | -21.00%566.13K | -21.00%559.04K | -28.37%2.66M | -32.88%620.92K |
| Other net income (expenses) | -61.27%1.45M | -56.39%1.22M | -156.61%-714.51K | -42.13%6.02M | 38.07%-1.78M | 3.02%3.74M | -45.47%2.8M | -72.06%1.26M | -54.34%10.4M | -134.37%-2.88M |
| Gain on sale of security | 91.57%-550 | 176.95%15.17K | 311.04%25.68K | -222.43%-82.93K | -1,236.94%-44.52K | 80.45%-6.52K | -161.20%-19.72K | 42.73%-12.17K | -132.60%-25.72K | -101.94%-3.33K |
| Special income (charges) | ---- | ---- | ---- | ---38.07K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Write off | ---- | ---- | ---- | --38.07K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | --631.56K | --0 | ---- | --631.56K | ---- | ---- | ---- |
| Income before tax | -46.33%1.05M | -69.04%380.71K | -38.85%-1.19M | 71.77%-954.58K | 41.52%-3.29M | 75.21%1.96M | 95.69%1.23M | -271.34%-855.83K | -130.52%-3.38M | -271.17%-5.63M |
| Income tax | 408.94K | 327.29K | -253.88K | -65.27%973.18K | 973.18K | 0 | 0 | 0 | -43.63%2.8M | |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -67.15%645.48K | -95.66%53.42K | -9.19%-934.46K | 68.83%-1.93M | 49.41%-4.27M | 75.21%1.96M | 95.69%1.23M | -271.34%-855.83K | -201.20%-6.18M | -401.51%-8.43M |
| Net income continuous operations | -67.15%645.48K | -95.66%53.42K | -9.19%-934.46K | 68.83%-1.93M | 49.41%-4.27M | 75.21%1.96M | 95.69%1.23M | -271.34%-855.83K | -201.20%-6.18M | -401.51%-8.43M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -67.15%645.48K | -95.66%53.42K | -9.19%-934.46K | 68.83%-1.93M | 49.41%-4.27M | 75.21%1.96M | 95.69%1.23M | -271.34%-855.83K | -201.20%-6.18M | -401.51%-8.43M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -67.15%645.48K | -95.66%53.42K | -9.19%-934.46K | 68.83%-1.93M | 49.41%-4.27M | 75.21%1.96M | 95.69%1.23M | -271.34%-855.83K | -201.20%-6.18M | -401.51%-8.43M |
| Diluted earnings per share | -50.00%0.01 | 0 | 0.00%-0.01 | 71.43%-0.02 | 44.44%-0.05 | 100.00%0.02 | 0.00%0.01 | -200.00%-0.01 | -200.00%-0.07 | -350.00%-0.09 |
| Basic earnings per share | -50.00%0.01 | 0 | 0.00%-0.01 | 71.43%-0.02 | 44.44%-0.05 | 100.00%0.02 | 0.00%0.01 | -200.00%-0.01 | -200.00%-0.07 | -350.00%-0.09 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.